Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding of remimazolam to prevent emergence delirium after sevoflurane anesthesia in children
ChiCTR2500104472Phase 4Not yet recruiting
- Sponsor
- Shanghai Children's Medical Center, Guizhou Hospital, Shanghai Jiaotong University School of Medicine
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in Emergence agitation (EA), sponsored by Shanghai Children's Medical Center, Guizhou Hospital, Shanghai Jiaotong University School of Medicine. Primary endpoint: ED90 of remimazolam for preventing emergence delirium after sevoflurane anesthesia in children. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2500104472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104472.